Cost-effectiveness of empagliflozin in the UK in an EMPA-REG OUTCOME subgroup with type 2 diabetes and heart failure - Reifsnider, Odette S.; Kansal, Anuraag R.; Franke, Jennifer; Lee, Joseph; George, Jyothis T.; Brückmann, Martina; Kaspers, Stefan; Brand, Sarah B.; Ustyugova, Anastasia; Linden, Stephan; Stargardter, Matthew; Hau, Nikco (ESC heart failure, 2020)
Gesehen am 20.10.2025